Metformin targets multiple signaling pathways in cancer

Metformin targets multiple signaling pathways in cancer

Abstract Metformin, an inexpensive and well-tolerated oral agent commonly used in the first-line treatment of type 2 diabetes, has become the focus of intense research as a candidate anticancer agent. Here, we discuss the potential of metformin in cancer therapeutics, particularly its functions in m...

Full description

Bibliographic Details
Main Authors: Yong Lei, Yanhua Yi, Yang Liu, Xia Liu, Evan T. Keller, Chao-Nan Qian, Jian Zhang, Yi Lu
Format: Article
Language:English
Published: BMC 2017-01-01
Series:Chinese Journal of Cancer
Subjects:
Metformin
Signaling pathway
Cancer stem cell
Cancer
Online Access:http://link.springer.com/article/10.1186/s40880-017-0184-9

Similar Items

Similar Items